KANG

About KANG

Beijing Kangkang Shengshi Information Technology Co., Ltd., operating as KANG, is a national high-tech enterprise specializing in chronic disease management. Founded on March 25, 2011, by Zeng Mingfa, the company is headquartered in Beijing, China. KANG focuses on integrating smart hardware with cloud services and big data analytics to offer comprehensive health management solutions, particularly for hypertension.

The company's core product, Kangkang Blood Pressure, launched in 2013, was the first wearable smart blood pressure device in China that connects to a mobile app for real-time monitoring and data management. This system includes the hardware device, a cloud platform for data storage and analysis, an APP client, and an expert database. It allows users to track their blood pressure, share results with family or doctors, and receive intelligent diagnostics based on a risk assessment system provided by the China Hypertensive League. The business model has evolved to create a closed-loop ecosystem for hypertension management, encompassing smart blood pressure monitors, specialized services, a chronic disease-focused internet hospital, and health insurance products.

KANG serves individual users and collaborates with medical institutions. Its revenue streams are derived from the sale of its smart medical devices and value-added services through its platform. In September 2016, the company secured a significant RMB 30 million in a Series A+ funding round from a subsidiary of Shijiazhuang Yiling Pharmaceutical, which acquired a 20% stake. This investment was aimed at developing the Guiyang Kangkang Chronic Disease Internet Hospital, the first of its kind in China, to provide specialized online secondary consultations and health management.